Lista de obras -

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer

artículo científico publicado en 2019

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer

artículo científico publicado en 2019

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.

artículo científico publicado en 2016

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis.

artículo científico publicado en 2016

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis

artículo científico publicado en 2019

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

artículo científico publicado en 2017

De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance

artículo científico publicado en 2017

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

artículo científico publicado en 2015

Embryonic transcription factor SOX9 drives breast cancer endocrine resistance

artículo científico publicado en 2017

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

artículo científico publicado en 2020

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

scientific article published on 11 December 2019

GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer

artículo científico publicado en 2018

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

artículo científico publicado en 2017

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

artículo científico publicado en 2020

Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications

artículo científico publicado en 2017

Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy

artículo científico publicado en 2019

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

artículo científico publicado en 2017

Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study

artículo científico publicado en 2020

Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study.

artículo científico publicado en 2015

Neratinib in HER2-Positive Breast Cancer Patients

scientific article published on 04 January 2019

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells

artículo científico publicado en 2017

Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.

artículo científico publicado en 2017

Resistance to Anti-HER2 Therapies in Breast Cancer.

artículo científico

Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients

scientific article published on 07 December 2018

Tamoxifen resistance in breast cancer is regulated by the EZH2-ERα-GREB1 transcriptional axis.

artículo científico publicado en 2017

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer

scientific article published on 16 August 2019

The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer

artículo científico publicado en 2017

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance

artículo científico publicado en 2018

Towards personalized treatment for early stage HER2-positive breast cancer

artículo científico publicado en 2019

Tumor characteristics and prognosis in familial breast cancer.

artículo científico publicado en 2016

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities

artículo científico publicado en 2016

Lista de obras de

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis.

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis

Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

Embryonic transcription factor SOX9 drives breast cancer endocrine resistance

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications

Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study

Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study.

Neratinib in HER2-Positive Breast Cancer Patients

PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells

Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.

Resistance to Anti-HER2 Therapies in Breast Cancer.

Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients

Tamoxifen resistance in breast cancer is regulated by the EZH2-ERα-GREB1 transcriptional axis.

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer

The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance

Towards personalized treatment for early stage HER2-positive breast cancer

Tumor characteristics and prognosis in familial breast cancer.

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities